Metastatic epithelial or neuroendocrine malignancy identified on the basis of histology/cytology, with no primary site detected despite a selected initial screen of investigations, before specialist review and possible further specialized investigations.

Diagnosis and management of metastatic malignant disease of unknown primary origin.
NICE clinical guide 104. Internet. Accessed September 1, 2017.